The trademark application OBZEFY was filed by NewAmsterdam Pharma B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on October 20, 2024, and still open for oppositions.
The application was filed in Dutch (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for lowering cholesterol
Pharmaceuticals, namely, lipid lowering agents
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders, major adverse cardiac events, cholesterol-related diseases and disorders, dyslipidemia, lipid-related diseases and disorders, diabetes, age-related macular degeneration, neurodegenerative diseases and disorders, dementia, Lewy body dementia, and Alzheimer’s disease.